The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
10x Genomics, Inc. CL A COM 88025u109 23,124 303,984 SH   SOLE   303,984 0 0
908 Devices Inc. COM 65443P102 380 20,000 SH   SOLE   20,000 0 0
Aadi Bioscience, Inc. COM 00032Q104 8,932 526,329 SH   SOLE   526,329 0 0
Adicet Bio, Inc. COM 007002108 11,583 580,000 SH   SOLE   580,000 0 0
Albireo Pharma, Inc. COM 01345P106 15,462 518,342 SH   SOLE   518,342 0 0
Alpine Immune Sciences, Inc. COM 02083G100 42,233 4,708,288 SH   SOLE   4,708,288 0 0
Arcus BioSciences, Inc. COM 03969f109 27,451 869,790 SH   SOLE   869,790 0 0
AtriCure Inc. COM 004963C20 3,038 46,259 SH   SOLE   46,259 0 0
Aura Biosciences, Inc. COM 05153U107 4,620 210,000 SH   SOLE   210,000 0 0
BeyondSpring Inc. SHS G10830100 10,908 4,958,142 SH   SOLE   4,958,142 0 0
Checkmate Pharamaceuticals, Inc. COM 162818108 4,253 1,333,254 SH   SOLE   1,333,254 0 0
Cue Health Inc. COM 229790100 57,927 8,980,909 SH   SOLE   8,980,909 0 0
Equillium Inc. COM 29446K106 14,009 4,447,308 SH   SOLE   4,447,308 0 0
Illumnia, Inc. COM 452327109 53,891 154,238 SH   SOLE   154,238 0 0
Mersana Therapeutics, Inc. COM 59045L106 3,608 904,268 SH   SOLE   904,268 0 0
Nautilus Biotechnology, Inc. COM 63909J108 1,302 300,000 SH   SOLE   300,000 0 0
NeuBase Therapeutics, Inc. COM 64132K102 1,880 1,000,000 SH   SOLE   1,000,000 0 0
Owlet, Inc. COM CL A 69120X107 3,998 898,400 SH   SOLE   898,400 0 0
Pacific Biosciences of California, Inc. COM 69404D108 13,321 1,463,872 SH   SOLE   1,463,872 0 0
Prometheus Biosciences, Inc. COM 74349U108 9,440 250,000 SH   SOLE   250,000 0 0
Scynexis Inc. COM NEW 811292200 2,172 555,555 SH   SOLE   555,555 0 0
Sema4 Holings Corp. COM CL A 81663L101 10,496 3,418,929 SH   SOLE   3,418,929 0 0
Singular Genomics Systems, Inc. COM 82933R100 126 20,000 SH   SOLE   20,000 0 0
Terns Pharmaceuticals, Inc. COM 880881107 2,121 714,285 SH   SOLE   714,285 0 0